Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATGross ProfitShares OutstandingShares Outstanding
Ratios

Goldenwell Biotech (GWLL) Leases (2021 - 2022)

Goldenwell Biotech filings provide 2 years of Leases readings, the most recent being $26346.0 for Q4 2022.

  • On a quarterly basis, Leases fell 45.96% to $26346.0 in Q4 2022 year-over-year; TTM through Dec 2022 was $26346.0, a 45.96% decrease, with the full-year FY2022 number at $26346.0, down 45.96% from a year prior.
  • Leases hit $26346.0 in Q4 2022 for Goldenwell Biotech, down from $31075.0 in the prior quarter.
  • In the past five years, Leases ranged from a high of $63561.0 in Q1 2021 to a low of $26346.0 in Q4 2022.